Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
The goal is to keep what you need at hand and know how to access it, but medical record organization can be challenging in a …
Organizations across the globe – including Screen4Rare – are working to bring life-saving screening tests to babies, wherever…
Feeling burned out from managing a chronic medical condition? We asked five experts for their advice on recognizing burnout a…
For patients who have symptoms and no diagnosis, it may take years to get an answer. EURORDIS hosted a webinar about “the dia…
The organization founded by Philadelphia’s Dr. David Fajgenbaum recently received a big funding boost from a U.S. health agen…
Infusion nurses administer intravenous and subcutaneous medicines. They also help train patients and caregivers to self-infus…
If you have a rare or chronic condition, start with your doctor and patient advocacy organizations.
The nonprofit group gives $20,000 grants to rare disease researchers every year. One scientist who received the award in 2022…
EURORDIS, which represents rare disease patients in Europe, celebrates advocates who distinguish themselves in categories inc…
A new survey of more than 1,000 U.S. residents finds that few know how common rare diseases are, but 85% said it was importan…
Few Australians understand how common rare diseases are, but 89% said it was important to research innovative new treatments,…
This February 29, we bring our collective focus to the cause and demonstrate the power of showing our stripes, says therapist…
Americas
Asia Pacific
Middle East
Europe
